Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Plasma cell 1 CNS 1

Conditions

Neuroma, Acoustic 1 Neurofibromatosis 2 1

Interventions

Temozolomide 66 Radiotherapy 52 Carboplatin 25 Bevacizumab 21 Cisplatin 19 Vincristine 17 Radiosurgery 17 Etoposide 17 Cyclophosphamide 17 Surgical Procedures, Operative 13 Magnetic Resonance Spectroscopy 13 Chemotherapy, Adjuvant 11 Melphalan 10 Lomustine 10 Drug Therapy 10 Filgrastim 9 Erlotinib Hydrochloride 9 apatinib 8 Pemetrexed 8 3-Iodobenzylguanidine 8 anlotinib 7 Radiation 7 Peripheral Blood Stem Cell Transplantation 7 Methotrexate 7 Thiotepa 6 Isotretinoin 6 Irinotecan 6 Ifosfamide 6 Doxorubicin 6 Carmustine 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × 89Zr-bevacizumab × CNS × Clear all

NCT05685836 2024-03-20

89Zr-Bevacizumab PET/CT Imaging in NF2 Patients

Leiden University Medical Center

Neuroma, Acoustic, Neurofibromatosis 2

Data powered by HemOnc (CC BY 4.0) Colophon ⚡